Peterlabs Holdings Bhd (XKLS:0171) OCF Margin %: 0.00% (As of Jun. 2025)


XKLS:0171 Peterlabs Holdings Bhd XKLS:0171
47 GF Score
Price RM0.24
GF Value RM0.20
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Peterlabs Holdings Bhd OCF Margin %?

Peterlabs Holdings Bhd XKLS:0171 47 OCF Margin % is 0.00% as of Jun. 2025. GuruFocus rates XKLS:0171 with a GF Score™ of 47/100 and a GF Value™ of RM0.20 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 959 Drug Manufacturers companies, Peterlabs Holdings Bhd ranks worse than 66.21% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Peterlabs Holdings Bhd's Cash Flow from Operations for the three months ended in Jun. 2025 was RM0.0 Mil. Peterlabs Holdings Bhd's Revenue for the three months ended in Jun. 2025 was RM31.8 Mil. Therefore, Peterlabs Holdings Bhd's OCF Margin % for the quarter that ended in Jun. 2025 was 0.00%.

As of today, Peterlabs Holdings Bhd's current OCF Yield % is 6.83%.

The historical rank and industry rank for Peterlabs Holdings Bhd's OCF Margin % or its related term are showing as below:

XKLS:0171' s OCF Margin % Range Over the Past 10 Years
Min: -1.44   Med: 3.55   Max: 12.23
Current: 2.96


During the past 13 years, the highest OCF Margin % of Peterlabs Holdings Bhd was 12.23%. The lowest was -1.44%. And the median was 3.55%.

XKLS:0171's OCF Margin % is ranked worse than
66.21% of 959 companies
in the Drug Manufacturers industry
Industry Median: 9.94 vs XKLS:0171: 2.96


Peterlabs Holdings Bhd OCF Margin % Related Terms


Peterlabs Holdings Bhd OCF Margin % Historical Data

* Premium members only.

The historical data trend for Peterlabs Holdings Bhd's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Peterlabs Holdings Bhd OCF Margin % Chart

Peterlabs Holdings Bhd Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.98 12.23 3.14 3.95 2.91

Peterlabs Holdings Bhd Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.69 -2.80 10.91 0.00 0.00

XKLS:0171 vs ZTS, UTHR, VTRS: OCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Peterlabs Holdings Bhd's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Peterlabs Holdings Bhd OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Peterlabs Holdings Bhd's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Peterlabs Holdings Bhd's OCF Margin % falls into.


XKLS:0171
47GF Score
Peterlabs Holdings Bhd XKLS:0171
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Peterlabs Holdings Bhd OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Peterlabs Holdings Bhd's OCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=5.415/186.208
=2.91 %

Peterlabs Holdings Bhd's OCF Margin for the quarter that ended in Jun. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Jun. 2025 )/Revenue (Q: Jun. 2025 )
=0/31.764
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Peterlabs Holdings Bhd (XKLS:0171) has a OCF Margin % of 0.00% as of Jun. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Peterlabs Holdings Bhd and its competitors. According to the industry distribution chart, Peterlabs Holdings Bhd ranks #635 out of 959 companies in the Drug Manufacturers industry, placing it in the top 66.2%.
Is Peterlabs Holdings Bhd's OCF Margin % too high?
Peterlabs Holdings Bhd's current OCF Margin % is 0.00%. Based on the distribution chart, Peterlabs Holdings Bhd ranks #635 out of 959 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Peterlabs Holdings Bhd has a GF Score™ of 47/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Peterlabs Holdings Bhd's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Peterlabs Holdings Bhd ranks #635 out of 959 companies for OCF Margin %. This places Peterlabs Holdings Bhd in the lower half of its industry. The industry median OCF Margin % is 9.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Peterlabs Holdings Bhd and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Peterlabs Holdings Bhd's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Peterlabs Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Peterlabs Holdings Bhd (XKLS:0171) is currently considered Modestly Overvalued. The stock's GF Value™ is RM0.20, compared to a current price of RM0.24 — trading 17.5% above its estimated fair value. The current OCF Margin % is 0.00%. Peterlabs Holdings Bhd's overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Peterlabs Holdings Bhd (XKLS:0171), the current OCF Margin % is 0.00% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Peterlabs Holdings Bhd (XKLS:0171) Overvalued in 2026?

Based on GuruFocus' analysis, Peterlabs Holdings Bhd stock appears to be overvalued. The current stock price of RM0.24 is trading 17.5% above its estimated GF Value™ of RM0.20. GuruFocus considers Peterlabs Holdings Bhd to be Modestly Overvalued.

Key valuation signals for XKLS:0171:

  • OCF Margin %: 0.00%
  • GF Value™: RM0.20 vs. price of RM0.24 (17.5% above fair value)
  • GF Score™: 47/100 with 6 warning signs

No single metric tells the full story. See the XKLS:0171 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Peterlabs Holdings Bhd Business Description

Address Jalan Nilam 3, Lot 16014 (PT No. 24341), Bandar Nilai Utama, Nilai, NSN, MYS, 71800
Peterlabs Holdings Bhd is engaged in the manufacturing, distribution, export, and trading of animal health and nutrition products. The Group offers biosecurity and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceuticals, and water-soluble supplements, as well as farm management, technical advisory services, raw material analysis, and feed formulation. Its segments are Manufacturing, which covers the manufacturing and distribution of animal health and nutrition products; Trading, which involves the trading and distribution of animal health and nutrition products and consumer goods, and contributes the majority of its revenue; and Others, which provides investment holding services. The company operates in Malaysia and internationally.
47GF Score

Get the complete analysis for XKLS:0171

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.24
Price
RM0.20
GF Value